← Back to Search

Anti-inflammatory Diet for Crohn's Disease (CD Trial)

N/A
Recruiting
Led By Zhaoping Li, MD, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
History of Crohn's Disease (CD) with mild to moderate symptoms and prior biopsy proof
Age of 18 to 75 years old
Must not have
History or current diagnosis of anorexia
History or current diagnosis of previous gastrointestinal surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will study how an anti-inflammatory diet affects patients with inflammatory bowel disease.

Who is the study for?
This trial is for adults aged 18-75 with mild to moderate Crohn's Disease, confirmed by a previous biopsy. Participants should not have severe other conditions like heart or liver disease, recent hospitalizations, substance abuse issues, or be pregnant. They must be willing to stop taking probiotics and certain medications without changing their dosage during the study.
What is being tested?
The study compares the effects of an anti-inflammatory diet versus a regular diet on patients with Crohn's Disease. It aims to see if the special diet can positively change gut bacteria diversity and function, which could provide insights into how diet affects this condition.
What are the potential side effects?
While specific side effects are not listed for dietary interventions, participants may experience changes in digestion or new food sensitivities as they adjust to the anti-inflammatory diet compared to their regular eating habits.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have mild to moderate Crohn's Disease confirmed by a biopsy.
Select...
I am between 18 and 75 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with or have a history of anorexia.
Select...
I have had surgery on my digestive system in the past.
Select...
I have or had kidney disease.
Select...
I have or had liver disease.
Select...
I have or had lung disease.
Select...
I have had heart surgery in the past or currently.
Select...
I have a history of heart disease.
Select...
I have or had an end enterostomy.
Select...
I have or had an endocrine disorder.
Select...
I have high blood pressure that hasn't been treated.
Select...
I urgently need surgery in my abdomen.
Select...
I have a history of bleeding disorders.
Select...
I am severely malnourished.
Select...
I have or had cancer.
Select...
I have a history of seizures or currently experience them.
Select...
I have a history of or currently experience chronic diarrhea.
Select...
I have had a stroke or have been diagnosed with an irregular heartbeat.
Select...
I am not changing my doses of immunosuppressants or similar drugs during the trial, except to reduce corticosteroids.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Efficacy of the anti-inflammatory whole food diet for the induction of remission in Crohn's Disease

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Anti-inflammatory whole foodExperimental Treatment1 Intervention
Included food items will include a defined minimum diversity of fruits, vegetables, and nuts based on complementary phytonutrient contents, particularly those rich in phenolic compounds such as ellagitannins and sulforaphanes. Selected herbs (e.g., curcumin), fermented foods, fats (e.g., avocado), and oils (e.g., olive oil) will be permitted or encouraged. Recommended portions of complex carbohydrates (50% - 60%) and lean proteins (20% - 30%) will form the basis of weight-based caloric needs. The goal is to have 5 servings of vegetables, 2 fruits per day, and 5 vegetable color groups per week. Vegetables with high insoluble fiber content will be cooked instead of eaten raw.
Group II: Regular DietActive Control1 Intervention
Patients in the control diet arm will be counseled to continue their regular diets and focus on recording all food intake.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,569 Previous Clinical Trials
10,314,179 Total Patients Enrolled
Zhaoping Li, MD, PhD4.76 ReviewsPrincipal Investigator - University of California, Los Angeles
Medical School - University of Illinois, Chicago
19 Previous Clinical Trials
764 Total Patients Enrolled
5Patient Review
Good

Media Library

Anti-inflammatory diet Clinical Trial Eligibility Overview. Trial Name: NCT04431700 — N/A
Crohn's Disease Research Study Groups: Regular Diet, Anti-inflammatory whole food
Crohn's Disease Clinical Trial 2023: Anti-inflammatory diet Highlights & Side Effects. Trial Name: NCT04431700 — N/A
Anti-inflammatory diet 2023 Treatment Timeline for Medical Study. Trial Name: NCT04431700 — N/A
~2 spots leftby Jan 2025